Low dose estrogen supplementation reduces mortality of mice in estrogen-dependent human tumor xenograft model

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 1, 2009, Pages 150-152

  Kang, Jong Soon ^a   Kang, Moo Rim ^a   Han, Sang Bae ^b   Yoon, Won Kee ^a   Kim, Jang Hyun ^a   Lee, Taek Chang ^a   Lee, Chang Woo ^a   Lee, Ki Hoon ^a   Lee, Kiho ^a   Park, Song Kyu ^a   Kim, Hwan Mook ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Breast cancer; Estrogen; MCF 7; Tumor xenograft model

Indexed keywords

ESTRADIOL; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER STONE; BREAST CANCER; CAUSE OF DEATH; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PELLET; DRUG RELEASE; ESTROGEN THERAPY; FEMALE; HISTOPATHOLOGY; KIDNEY INJURY; LOW DRUG DOSE; MORTALITY; MOUSE; NONHUMAN; PREGNANCY; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; KIDNEY DISEASES; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; OVARIECTOMY; SURVIVAL ANALYSIS; TIME FACTORS; URINARY BLADDER CALCULI;

EID: 59949095663     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.150     Document Type: Article

References (14)

1. Morito K., Hirose T., Kinjo J., Hirakawa T., Okawa M., Nohara T., Ogawa S., Inoue S., Muramatsu M., Masamune Y., Biol. Pharm. Bull., 24, 351-356 (2001).
2. Massarweh S., Osborne C. K., Creighton C. J., Qin L., Tsimelzon A., Huang S., Weiss H., Rimawi M., Schiff R., Cancer Res., 68, 826-833 (2008).
3. Foster P. A., Chander S. K., Parsons M. F., Newman S. P., Woo L. W., Potter B. V., Reed M. J., Purohit A., Breast Cancer Res. Treat., 111, 129-138 (2008).
4. Imanishi Y., Hu B., Jarzynka M. J., Guo P., Elishaev E., Bar-Joseph I., Cheng S. Y., Cancer Res., 67, 4254-4263 (2007).
5. Voskoglou-Nomikos T., Pater J. L., Seymour L., Clin. Cancer Res., 9, 4227-4239 (2007).
6. Sharpless N. E., Depinho R. A., Nat. Rev., 5, 741-754 (2006).
7. Hirokawa Y., Arnold M., Nakajima H., Zalcberg J., Maruta H., Cancer Biol. Ther., 4, 956-960 (2005).
8. Saarinen N. M., Power K., Chen J., Thompson L. U., Int. J. Cancer, 119, 925-931 (2006).
9. Momiyama M., Omori Y., Ishizaki Y., Nishikawa Y., Tokairin T., Ogawa J., Enomoto K., Cancer Sci., 94, 501-507 (2003).
10. Kim H. M., Lim J., Yoon Y. D., Ahn J. M., Kang J. S., Lee K., Park S. K., Jeong Y. J., Kim J. M., Han G., Yang K. H., Kim Y. J., Kim Y., Han S. B., Int. Immunopharmacol., 7, 1793-1801 (2007).
11. Tomayko M. M., Reynolds C. P., Cancer Chemother. Pharmacol., 24, 148-154 (1989).
12. Salvo V. A., Boue S. M., Fonseca J. P., Elliott S., Corbitt C., Collins-Burow B. M., Curiel T. J., Srivastav S. K., Shih B. Y., Carter-Wientjes C., Wood C. E., Erhardt P. W., Beckman B. S., McLachlan J. A., Cleveland T. E., Burow M. E., Clin. Cancer Res., 12, 7159-7164 (2006).
13. Mauro L., Catalano S., Bossi G., Pellegrino M., Barone I., Morales S., Giordano C., Bartella V., Casaburi I., Ando S., Cancer Res., 67, 3412-3421 (2007).
14. Meng X., D'Ambrosio M. A., Liao T.-D., Yang X.-P.: 〈http://www. sciencedaily.com/releases/2008/04/080407114608.htm〉, ScienceDaily, 9 April, 2008.